OSE’s Covid-19 vaccine shows promise in preclinical studies

OSE Immunotherapeutics has reported positive data from preclinical and human ex-vivo studies of its Covid-19 vaccine candidate, named CoVepiT.

Source: OSE’s Covid-19 vaccine shows promise in preclinical studies